ClinicalTrials.gg
Enrolling by invitationNCT07170423Updated Nov 12, 2026

Automated Text Message Reminders to Promote Hearing Aid Adoption

An interventional study of Automated text message reminder in Hearing Loss, sponsored by Stanford University. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Stanford University · Not applicable, Interventional, and Health services research

How we know

Updated Nov 12, 2026Now Enrolling by invitationStart date moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
190
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 321 studies in Hearing Loss with a site in United States — 82 open to participants now, 94 under way, 3 of them phase 3. Hearing Loss · United States.

Planned enrollment
54th of 272
190 · median 48
Started
2026
with 24 others
No phase
212 of 321
54 open now
Primary completion
2030-11
later than 88 of 93 live
Registered
295th of 321
by date

Among the 321 studies in Hearing Loss with a site in United States, this one is the 54th largest by planned enrollment of the 272 interventional ones that give a count, is one of 25 that started in 2026, is one of 212 with no phase, reaches primary completion later than 88 of the 93 other live ones, and was the 295th registered.

Hearing Loss

797 studies on the registry are indexed under Hearing Loss; 194 are open to participants now.

Browse Hearing Loss studies →

Open to participants now

82 of the 321 studies in Hearing Loss with a site in United States are open now. Recruiting first, the newest first:

77 more — sign in →

All 82 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Hearing Loss studies recruiting now, 60 (48%) set no upper age limit and 43 (34%) stop at 75 or younger; 47 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 321 studies in Hearing Loss with a site in United States, or all of them as a file.
02

Study summary

Many individuals with hearing loss do not receive adequate hearing healthcare. Only about 30 percent of people that are found to have hearing loss during a hearing test go on to use hearing aids. The investigators propose to test the use of text message reminders to educate patients with hearing loss, and to encourage them to get hearing aids. The study objective is to examine whether automated text-messaging reminders increase the use of hearing aids among patients with hearing loss, who are hearing aid candidates.

03

Conditions studied

  • Hearing Loss

Browse trials for

Keywords

  • hearing loss
  • hearing aid
  • text message
  • patient reminders
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English-speaking adult patients who have been recommended for hearing aids.

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded if they use hearing aids or cochlear implants.
  • Patients without a valid cellphone number will be excluded.
  • Patients with dementia will also be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
190 participants (estimated)

Study arms

  • Experimental
    Automated Text Message Reminder

    Participants in the intervention group will receive automated text messages instructing them to obtain hearing aids. The messages will also include basic information on the prevalence and negative effects of hearing loss.

    Behavioral: Automated text message reminder

  • No intervention
    Control Group

Interventions

  • BehavioralAutomated text message reminder

    Participants in the intervention group will receive automated text messages instructing them to obtain hearing aids. The messages will also include basic information on the prevalence and negative effects of hearing loss.

06

What researchers measure

Primary outcomes

  1. Likelihood of obtaining hearing aids

    Participants will be queried on whether they have obtained hearing aids since enrollment in the study. Participants who have not obtained hearing aids, will be asked to rate the likelihood that they would obtain hearing aids. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already obtained hearing aids will be assigned a score of 10.

    Time frame: This outcome data will be collected 3, 6, 9, and 12 months after enrollment.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Nov 2030, 48 months after the start.

Of 197 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 48 months is above that.

Counting every sponsor, half of 323 studies reached it within 19 months; a quarter within 5 and three quarters within 42.

Start moved twice since we started tracking on Sep 25, 2026: Nov 2025 → Nov 2026, last on Nov 12, 2026.

Primary completion moved once since we started tracking on Sep 25, 2026: Nov 2027 → Nov 2030, on Oct 30, 2026.

Completion moved once since we started tracking on Sep 25, 2026: Nov 2027 → Dec 2030, on Oct 30, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2025
First posted
Sep 12, 2025
StartActual
Nov 6, 2026was Nov 2025
Primary completionEst.
Nov 2030was Nov 2027
CompletionEst.
Dec 2030was Nov 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Nov 12, 2026
Start date
Nov 2025→Nov 6, 2026 (actual)
moved 2 times, Oct 30, 2026 – Nov 12, 2026
Primary completion
Nov 2027→Nov 2030
Oct 30, 2026
Study completion
Nov 2027→Dec 2030
Oct 30, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Stanford University · Stanford, United StatesContact removed (no phone or email listed)
Nov 12, 2026
Show all 2 updates
  1. Nov 12, 2026
    Not yet recruiting→Enrolling by invitation
    Start date Oct 2026→Nov 6, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Stanford University · Stanford, United StatesContact removed (no phone or email listed)
    + 1 other change: verification date
  2. Oct 30, 2026
    Start date Nov 2025→Oct 2026
    Primary completion Nov 2027→Nov 2030
    Study completion Nov 2027→Dec 2030
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07170423
Responsible party
Uchechukwu Megwalu (Professor of Otolaryngology - Head & Neck Surgery, Stanford University) — Principal investigator
First posted
Sep 12, 2025
Start date
Nov 6, 2026
Primary completion
Nov 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion